JP4990886B2 - 改良ポリメラーゼ - Google Patents
改良ポリメラーゼ Download PDFInfo
- Publication number
- JP4990886B2 JP4990886B2 JP2008510637A JP2008510637A JP4990886B2 JP 4990886 B2 JP4990886 B2 JP 4990886B2 JP 2008510637 A JP2008510637 A JP 2008510637A JP 2008510637 A JP2008510637 A JP 2008510637A JP 4990886 B2 JP4990886 B2 JP 4990886B2
- Authority
- JP
- Japan
- Prior art keywords
- polymerase
- dna
- nucleotide
- amino acid
- nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 125000003729 nucleotide group Chemical group 0.000 claims description 195
- 239000002773 nucleotide Substances 0.000 claims description 156
- 230000035772 mutation Effects 0.000 claims description 87
- 238000006243 chemical reaction Methods 0.000 claims description 71
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 63
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 60
- 235000001014 amino acid Nutrition 0.000 claims description 58
- 238000006467 substitution reaction Methods 0.000 claims description 55
- 238000000034 method Methods 0.000 claims description 48
- 150000007523 nucleic acids Chemical class 0.000 claims description 46
- 150000001413 amino acids Chemical class 0.000 claims description 45
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 43
- 102000039446 nucleic acids Human genes 0.000 claims description 41
- 108020004707 nucleic acids Proteins 0.000 claims description 41
- 238000010348 incorporation Methods 0.000 claims description 40
- 230000002829 reductive effect Effects 0.000 claims description 38
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 24
- 239000013598 vector Substances 0.000 claims description 20
- 239000002157 polynucleotide Substances 0.000 claims description 18
- 102000040430 polynucleotide Human genes 0.000 claims description 16
- 108091033319 polynucleotide Proteins 0.000 claims description 16
- 239000013604 expression vector Substances 0.000 claims description 13
- 235000004279 alanine Nutrition 0.000 claims description 11
- 125000001424 substituent group Chemical group 0.000 claims description 11
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 description 74
- 108090000790 Enzymes Proteins 0.000 description 74
- 229940088598 enzyme Drugs 0.000 description 74
- 108090000623 proteins and genes Proteins 0.000 description 31
- 238000012163 sequencing technique Methods 0.000 description 31
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 28
- 238000003556 assay Methods 0.000 description 23
- 238000002360 preparation method Methods 0.000 description 22
- 102220526527 DNA (cytosine-5)-methyltransferase 3A_K705A_mutation Human genes 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 21
- 230000000694 effects Effects 0.000 description 21
- 102220474970 Ran-specific GTPase-activating protein_R713C_mutation Human genes 0.000 description 19
- 102220539099 Signal-induced proliferation-associated 1-like protein 2_R743A_mutation Human genes 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- 239000000499 gel Substances 0.000 description 18
- 230000008859 change Effects 0.000 description 17
- 238000003491 array Methods 0.000 description 16
- 230000004568 DNA-binding Effects 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 15
- 102000004169 proteins and genes Human genes 0.000 description 15
- 238000000746 purification Methods 0.000 description 15
- 102220010377 rs104894722 Human genes 0.000 description 14
- 239000011780 sodium chloride Substances 0.000 description 14
- 238000012217 deletion Methods 0.000 description 13
- 230000037430 deletion Effects 0.000 description 13
- 238000010494 dissociation reaction Methods 0.000 description 13
- 230000005593 dissociations Effects 0.000 description 13
- 230000014509 gene expression Effects 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 12
- 210000003813 thumb Anatomy 0.000 description 12
- 102000053602 DNA Human genes 0.000 description 11
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 11
- 241000283891 Kobus Species 0.000 description 11
- 108091028043 Nucleic acid sequence Proteins 0.000 description 11
- 239000012071 phase Substances 0.000 description 11
- 239000013078 crystal Substances 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 239000002777 nucleoside Substances 0.000 description 10
- 230000008901 benefit Effects 0.000 description 9
- 230000002255 enzymatic effect Effects 0.000 description 9
- 239000012634 fragment Substances 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 8
- 230000002411 adverse Effects 0.000 description 8
- 230000027455 binding Effects 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 239000011534 wash buffer Substances 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 230000003321 amplification Effects 0.000 description 7
- 230000000903 blocking effect Effects 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 150000003833 nucleoside derivatives Chemical group 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 7
- 108020004705 Codon Proteins 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 6
- 210000004899 c-terminal region Anatomy 0.000 description 6
- 125000005647 linker group Chemical group 0.000 description 6
- -1 sequencing reactions Substances 0.000 description 6
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000004475 Arginine Substances 0.000 description 5
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 5
- 239000007984 Tris EDTA buffer Substances 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 125000000539 amino acid group Chemical class 0.000 description 5
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000011109 contamination Methods 0.000 description 5
- 239000007850 fluorescent dye Substances 0.000 description 5
- 238000002703 mutagenesis Methods 0.000 description 5
- 231100000350 mutagenesis Toxicity 0.000 description 5
- 230000002018 overexpression Effects 0.000 description 5
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
- 241000203069 Archaea Species 0.000 description 4
- 108010017826 DNA Polymerase I Proteins 0.000 description 4
- 102000004594 DNA Polymerase I Human genes 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 4
- 238000011088 calibration curve Methods 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000006166 lysate Substances 0.000 description 4
- 239000012139 lysis buffer Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 108020004634 Archaeal DNA Proteins 0.000 description 3
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- ZYFVNVRFVHJEIU-UHFFFAOYSA-N PicoGreen Chemical compound CN(C)CCCN(CCCN(C)C)C1=CC(=CC2=[N+](C3=CC=CC=C3S2)C)C2=CC=CC=C2N1C1=CC=CC=C1 ZYFVNVRFVHJEIU-UHFFFAOYSA-N 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 3
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 125000003835 nucleoside group Chemical group 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000012266 salt solution Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000007480 sanger sequencing Methods 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 2
- 101150106774 9 gene Proteins 0.000 description 2
- 208000035657 Abasia Diseases 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 241000205156 Pyrococcus furiosus Species 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 241001495444 Thermococcus sp. Species 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 241000617156 archaeon Species 0.000 description 2
- 230000006037 cell lysis Effects 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 230000009881 electrostatic interaction Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000002741 site-directed mutagenesis Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 102000040717 Alpha family Human genes 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 101710192606 Latent membrane protein 2 Proteins 0.000 description 1
- 101000578786 Leishmania major Membrane antigen containing repeating peptides Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 101100117496 Sulfurisphaera ohwakuensis pol-alpha gene Proteins 0.000 description 1
- 101710109576 Terminal protein Proteins 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 241000205188 Thermococcus Species 0.000 description 1
- 241000205180 Thermococcus litoralis Species 0.000 description 1
- 101000865057 Thermococcus litoralis DNA polymerase Proteins 0.000 description 1
- 108010001244 Tli polymerase Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical class N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000001118 alkylidene group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 241000600454 bacterium T7 Species 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000005546 dideoxynucleotide Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- 125000005553 heteroaryloxy group Chemical group 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000012933 kinetic analysis Methods 0.000 description 1
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000000302 molecular modelling Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000003203 nucleic acid sequencing method Methods 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- IGFXRKMLLMBKSA-UHFFFAOYSA-N purine Chemical compound N1=C[N]C2=NC=NC2=C1 IGFXRKMLLMBKSA-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 230000036964 tight binding Effects 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07007—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0509508A GB0509508D0 (en) | 2005-05-10 | 2005-05-10 | Improved polymerases |
| GB0509508.8 | 2005-05-10 | ||
| US75799706P | 2006-01-11 | 2006-01-11 | |
| US60/757,997 | 2006-01-11 | ||
| PCT/GB2006/001700 WO2006120433A1 (en) | 2005-05-10 | 2006-05-10 | Improved polymerases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008539750A JP2008539750A (ja) | 2008-11-20 |
| JP2008539750A5 JP2008539750A5 (https=) | 2009-06-25 |
| JP4990886B2 true JP4990886B2 (ja) | 2012-08-01 |
Family
ID=36645775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008510637A Expired - Fee Related JP4990886B2 (ja) | 2005-05-10 | 2006-05-10 | 改良ポリメラーゼ |
Country Status (4)
| Country | Link |
|---|---|
| US (4) | US8623628B2 (https=) |
| EP (1) | EP1888743B1 (https=) |
| JP (1) | JP4990886B2 (https=) |
| WO (1) | WO2006120433A1 (https=) |
Families Citing this family (389)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0321306D0 (en) | 2003-09-11 | 2003-10-15 | Solexa Ltd | Modified polymerases for improved incorporation of nucleotide analogues |
| EP1888743B1 (en) | 2005-05-10 | 2011-08-03 | Illumina Cambridge Limited | Improved polymerases |
| CA2648149A1 (en) | 2006-03-31 | 2007-11-01 | Solexa, Inc. | Systems and devices for sequence by synthesis analysis |
| US11940413B2 (en) | 2007-02-05 | 2024-03-26 | IsoPlexis Corporation | Methods and devices for sequencing nucleic acids in smaller batches |
| WO2009097368A2 (en) | 2008-01-28 | 2009-08-06 | Complete Genomics, Inc. | Methods and compositions for efficient base calling in sequencing reactions |
| US9017973B2 (en) | 2008-03-19 | 2015-04-28 | Intelligent Biosystems, Inc. | Methods and compositions for incorporating nucleotides |
| US8039817B2 (en) | 2008-05-05 | 2011-10-18 | Illumina, Inc. | Compensator for multiple surface imaging |
| EP2294214A2 (en) * | 2008-05-07 | 2011-03-16 | Illumina, Inc. | Compositions and methods for providing substances to and from an array |
| CA2742593C (en) | 2008-11-03 | 2020-05-05 | Kapa Biosystems, Inc. | Chimeric dna polymerases |
| US8486865B2 (en) | 2008-11-03 | 2013-07-16 | The Regents Of The University Of California | Methods for detecting modification resistant nucleic acids |
| WO2010068702A2 (en) * | 2008-12-10 | 2010-06-17 | Illumina, Inc. | Methods and compositions for hybridizing nucleic acids |
| EP2607496B1 (en) | 2008-12-23 | 2014-07-16 | Illumina, Inc. | Methods useful in nucleic acid sequencing protocols |
| WO2010127304A2 (en) * | 2009-05-01 | 2010-11-04 | Illumina, Inc. | Sequencing methods |
| US10787701B2 (en) | 2010-04-05 | 2020-09-29 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
| US20190300945A1 (en) | 2010-04-05 | 2019-10-03 | Prognosys Biosciences, Inc. | Spatially Encoded Biological Assays |
| WO2011127099A1 (en) | 2010-04-05 | 2011-10-13 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
| US9777320B2 (en) | 2010-08-25 | 2017-10-03 | Pacific Biosciences Of California, Inc. | Molecular adaptors for dye conjugates |
| US9029103B2 (en) | 2010-08-27 | 2015-05-12 | Illumina Cambridge Limited | Methods for sequencing polynucleotides |
| US8483969B2 (en) | 2010-09-17 | 2013-07-09 | Illuminia, Inc. | Variation analysis for multiple templates on a solid support |
| WO2012050920A1 (en) | 2010-09-29 | 2012-04-19 | Illumina, Inc. | Compositions and methods for sequencing nucleic acids |
| EP2633069B1 (en) | 2010-10-26 | 2015-07-01 | Illumina, Inc. | Sequencing methods |
| EP2632593B1 (en) | 2010-10-27 | 2021-09-29 | Illumina, Inc. | Flow cells for biological or chemical analysis |
| US8575071B2 (en) | 2010-11-03 | 2013-11-05 | Illumina, Inc. | Reducing adapter dimer formation |
| WO2012061832A1 (en) | 2010-11-05 | 2012-05-10 | Illumina, Inc. | Linking sequence reads using paired code tags |
| WO2012074855A2 (en) | 2010-11-22 | 2012-06-07 | The Regents Of The University Of California | Methods of identifying a cellular nascent rna transcript |
| GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
| US20130040365A1 (en) | 2011-08-10 | 2013-02-14 | Life Technologies Corporation | Polymerase compositions, methods of making and using same |
| US11208636B2 (en) | 2011-08-10 | 2021-12-28 | Life Technologies Corporation | Polymerase compositions, methods of making and using same |
| AU2012316218B2 (en) | 2011-09-26 | 2016-03-17 | Gen-Probe Incorporated | Algorithms for sequence determinations |
| US8637242B2 (en) | 2011-11-07 | 2014-01-28 | Illumina, Inc. | Integrated sequencing apparatuses and methods of use |
| US9200274B2 (en) | 2011-12-09 | 2015-12-01 | Illumina, Inc. | Expanded radix for polymeric tags |
| WO2013117595A2 (en) | 2012-02-07 | 2013-08-15 | Illumina Cambridge Limited | Targeted enrichment and amplification of nucleic acids on a support |
| NO2694769T3 (https=) | 2012-03-06 | 2018-03-03 | ||
| US9444880B2 (en) | 2012-04-11 | 2016-09-13 | Illumina, Inc. | Cloud computing environment for biological data |
| EP2850086B1 (en) | 2012-05-18 | 2023-07-05 | Pacific Biosciences Of California, Inc. | Heteroarylcyanine dyes |
| US9315864B2 (en) | 2012-05-18 | 2016-04-19 | Pacific Biosciences Of California, Inc. | Heteroarylcyanine dyes with sulfonic acid substituents |
| US20150167084A1 (en) | 2012-07-03 | 2015-06-18 | Sloan Kettering Institute For Cancer Research | Quantitative Assessment of Human T-Cell Repertoire Recovery After Allogeneic Hematopoietic Stem Cell Transplantation |
| NL2017959B1 (en) | 2016-12-08 | 2018-06-19 | Illumina Inc | Cartridge assembly |
| EP4592400A3 (en) | 2012-10-17 | 2025-10-29 | 10x Genomics Sweden AB | Methods and product for optimising localised or spatial detection of gene expression in a tissue sample |
| US9116139B2 (en) | 2012-11-05 | 2015-08-25 | Illumina, Inc. | Sequence scheduling and sample distribution techniques |
| US9805407B2 (en) | 2013-01-25 | 2017-10-31 | Illumina, Inc. | Methods and systems for using a cloud computing environment to configure and sell a biological sample preparation cartridge and share related data |
| US9650406B2 (en) | 2013-02-28 | 2017-05-16 | Centrillion Technology Holdings Corporation | Reversible terminator molecules and methods of their use |
| ES2620423T3 (es) | 2013-03-08 | 2017-06-28 | Illumina Cambridge Limited | Compuestos de polimetina y su uso como marcadores fluorescentes |
| DK2964624T3 (en) | 2013-03-08 | 2017-04-03 | Illumina Cambridge Ltd | RHODAMINE COMPOUNDS AND USE AS FLUORESCING LABELS |
| DK2970951T3 (da) | 2013-03-13 | 2019-05-13 | Illumina Inc | Fremgangsmåder til nukleinsyresekventering |
| EP2971070B2 (en) | 2013-03-14 | 2021-03-03 | Illumina, Inc. | Modified polymerases for improved incorporation of nucleotide analogues |
| US9146248B2 (en) | 2013-03-14 | 2015-09-29 | Intelligent Bio-Systems, Inc. | Apparatus and methods for purging flow cells in nucleic acid sequencing instruments |
| US9591268B2 (en) | 2013-03-15 | 2017-03-07 | Qiagen Waltham, Inc. | Flow cell alignment methods and systems |
| US8808989B1 (en) | 2013-04-02 | 2014-08-19 | Molecular Assemblies, Inc. | Methods and apparatus for synthesizing nucleic acids |
| US11384377B2 (en) | 2013-04-02 | 2022-07-12 | Molecular Assemblies, Inc. | Reusable initiators for synthesizing nucleic acids |
| US9771613B2 (en) | 2013-04-02 | 2017-09-26 | Molecular Assemblies, Inc. | Methods and apparatus for synthesizing nucleic acid |
| US11331643B2 (en) | 2013-04-02 | 2022-05-17 | Molecular Assemblies, Inc. | Reusable initiators for synthesizing nucleic acids |
| US10683536B2 (en) | 2013-04-02 | 2020-06-16 | Molecular Assemblies, Inc. | Reusable initiators for synthesizing nucleic acids |
| US9279149B2 (en) | 2013-04-02 | 2016-03-08 | Molecular Assemblies, Inc. | Methods and apparatus for synthesizing nucleic acids |
| CA2916662C (en) | 2013-06-25 | 2022-03-08 | Prognosys Biosciences, Inc. | Methods and systems for determining spatial patterns of biological targets in a sample |
| CN105358715B (zh) | 2013-07-03 | 2018-09-18 | 伊鲁米那股份有限公司 | 正交合成测序 |
| US9352315B2 (en) | 2013-09-27 | 2016-05-31 | Taiwan Semiconductor Manufacturing Company, Ltd. | Method to produce chemical pattern in micro-fluidic structure |
| US10540783B2 (en) | 2013-11-01 | 2020-01-21 | Illumina, Inc. | Image analysis useful for patterned objects |
| CA3181696A1 (en) | 2013-12-03 | 2015-06-11 | Paul BELITZ | Methods and systems for analyzing image data |
| CA2932916C (en) | 2013-12-10 | 2021-12-07 | Illumina, Inc. | Biosensors for biological or chemical analysis and methods of manufacturing the same |
| US10537889B2 (en) | 2013-12-31 | 2020-01-21 | Illumina, Inc. | Addressable flow cell using patterned electrodes |
| KR101982388B1 (ko) | 2014-02-13 | 2019-05-27 | 일루미나, 인코포레이티드 | 통합된 소비자 게놈 서비스 |
| HRP20210953T1 (hr) | 2014-02-18 | 2021-09-03 | Illumina, Inc. | Postupci i pripravci za određivanje dnk profila |
| EP3116651B1 (en) | 2014-03-11 | 2020-04-22 | Illumina, Inc. | Disposable, integrated microfluidic cartridge and methods of making it |
| GB201408077D0 (en) | 2014-05-07 | 2014-06-18 | Illumina Cambridge Ltd | Polymethine compounds and their use as fluorescent labels |
| CA3219413A1 (en) | 2014-05-16 | 2015-11-19 | Illumina, Inc. | Nucleic acid synthesis techniques |
| AU2015267189B2 (en) | 2014-05-27 | 2019-12-05 | Illumina, Inc. | Systems and methods for biochemical analysis including a base instrument and a removable cartridge |
| US20150353989A1 (en) | 2014-06-09 | 2015-12-10 | Illumina Cambridge Limited | Sample preparation for nucleic acid amplification |
| EP3702471B1 (en) * | 2014-06-27 | 2025-12-24 | Illumina, Inc. | Modified polymerases for improved incorporation of nucleotide analogues |
| EP3778891A1 (en) | 2014-08-27 | 2021-02-17 | New England Biolabs, Inc. | Synthon formation |
| US9963687B2 (en) | 2014-08-27 | 2018-05-08 | New England Biolabs, Inc. | Fusion polymerase and method for using the same |
| WO2016040602A1 (en) | 2014-09-11 | 2016-03-17 | Epicentre Technologies Corporation | Reduced representation bisulfite sequencing using uracil n-glycosylase (ung) and endonuclease iv |
| CN107002051A (zh) | 2014-09-30 | 2017-08-01 | 亿明达股份有限公司 | 用于核苷酸类似物的改善的掺入的经修饰的聚合酶 |
| US9897791B2 (en) | 2014-10-16 | 2018-02-20 | Illumina, Inc. | Optical scanning systems for in situ genetic analysis |
| ES2768762T3 (es) | 2014-11-05 | 2020-06-23 | Illumina Cambridge Ltd | Reducción del daño al ADN durante la preparación de muestras y secuenciación usando agentes quelantes sideróforos |
| GB201419731D0 (en) | 2014-11-05 | 2014-12-17 | Illumina Cambridge Ltd | Sequencing from multiple primers to increase data rate and density |
| PT3218511T (pt) | 2014-11-11 | 2020-07-23 | Illumina Cambridge Ltd | Métodos e dispositivos para produção e sequenciamento de grupos monoclonais de ácido nucleico |
| WO2016124543A1 (en) | 2015-02-02 | 2016-08-11 | F. Hoffmann-La Roche Ag | Polymerase variants |
| CN107406890B (zh) | 2015-02-10 | 2023-07-18 | 亿明达股份有限公司 | 用于分析细胞组分的方法和组合物 |
| US10576471B2 (en) | 2015-03-20 | 2020-03-03 | Illumina, Inc. | Fluidics cartridge for use in the vertical or substantially vertical position |
| WO2016156845A1 (en) | 2015-03-31 | 2016-10-06 | Illumina Cambridge Limited | Surface concatamerization of templates |
| EP3901282B1 (en) | 2015-04-10 | 2023-06-28 | Spatial Transcriptomics AB | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
| EP3091026B1 (en) | 2015-05-08 | 2019-02-20 | Centrillion Technology Holdings Corporation | Disulfide-linked reversible terminators |
| US10526588B2 (en) | 2015-05-14 | 2020-01-07 | Roche Sequencing Solutions, Inc. | Polymerase variants and uses thereof |
| GB201508858D0 (en) | 2015-05-22 | 2015-07-01 | Illumina Cambridge Ltd | Polymethine compounds with long stokes shifts and their use as fluorescent labels |
| AU2016269785B2 (en) | 2015-05-29 | 2019-02-28 | Illumina Cambridge Limited | Enhanced utilization of surface primers in clusters |
| WO2016196358A1 (en) | 2015-05-29 | 2016-12-08 | Epicentre Technologies Corporation | Methods of analyzing nucleic acids |
| EP3878974A1 (en) | 2015-07-06 | 2021-09-15 | Illumina Cambridge Limited | Sample preparation for nucleic acid amplification |
| CA3176469A1 (en) | 2015-07-27 | 2017-02-02 | Illumina, Inc. | Spatial mapping of nucleic acid sequence information |
| WO2017019278A1 (en) | 2015-07-30 | 2017-02-02 | Illumina, Inc. | Orthogonal deblocking of nucleotides |
| DK3334839T3 (da) | 2015-08-14 | 2021-04-26 | Illumina Inc | Systemer og fremgangsmåder under anvendelse af magnetisk reagerende sensorer til bestemmelse af en genetisk egenskab |
| EP3338096B1 (en) | 2015-08-24 | 2024-03-06 | Illumina, Inc. | In-line pressure accumulator and flow-control system for biological or chemical assays |
| US20200231947A1 (en) * | 2015-09-09 | 2020-07-23 | Qiagen Gmbh | Polymerase enzyme |
| US10450598B2 (en) | 2015-09-11 | 2019-10-22 | Illumina, Inc. | Systems and methods for obtaining a droplet having a designated concentration of a substance-of-interest |
| GB201516987D0 (en) | 2015-09-25 | 2015-11-11 | Illumina Cambridge Ltd | Polymethine compounds and their use as fluorescent labels |
| US10577643B2 (en) | 2015-10-07 | 2020-03-03 | Illumina, Inc. | Off-target capture reduction in sequencing techniques |
| US10253352B2 (en) | 2015-11-17 | 2019-04-09 | Omniome, Inc. | Methods for determining sequence profiles |
| EP3904514A1 (en) | 2016-07-22 | 2021-11-03 | Oregon Health & Science University | Single cell whole genome libraries and combinatorial indexing methods of making thereof |
| JP6839268B2 (ja) | 2016-09-22 | 2021-03-03 | イルミナ インコーポレイテッド | 体細胞コピー数多型検出 |
| US10385214B2 (en) | 2016-09-30 | 2019-08-20 | Illumina Cambridge Limited | Fluorescent dyes and their uses as biomarkers |
| MY194951A (en) | 2016-10-14 | 2022-12-28 | Illumina Inc | Cartridge assembly |
| SG11201810611YA (en) | 2016-12-22 | 2018-12-28 | Illumina Cambridge Ltd | Coumarin compounds and their uses as fluorescent labels |
| ES3026859T3 (en) | 2017-01-04 | 2025-06-12 | Mgi Tech Co Ltd | Stepwise sequencing by non-labeled reversible terminators or natural nucleotides |
| US11150179B2 (en) | 2017-01-06 | 2021-10-19 | Illumina, Inc. | Phasing correction |
| BR112019014042A2 (pt) | 2017-01-17 | 2020-02-04 | Illumina, Inc. | determinação de variante de splice oncogênica |
| CA3050852C (en) | 2017-01-20 | 2021-03-09 | Omniome, Inc. | Genotyping by polymerase binding |
| CN110249059B (zh) | 2017-01-20 | 2021-04-13 | 欧姆尼欧美公司 | 核酸的等位基因特异性捕获 |
| EP3580351A1 (en) | 2017-02-13 | 2019-12-18 | Qiagen Sciences, LLC | Polymerase enzyme from 9°n |
| US20200377935A1 (en) | 2017-03-24 | 2020-12-03 | Life Technologies Corporation | Polynucleotide adapters and methods of use thereof |
| AU2018259206B2 (en) | 2017-04-23 | 2024-07-11 | Illumina Cambridge Limited | Compositions and methods for improving sample identification in indexed nucleic acid libraries |
| CN110770353B (zh) | 2017-04-23 | 2024-11-26 | 伊鲁米那股份有限公司 | 用于改进编索引的核酸文库中的样品鉴定的组合物和方法 |
| EP3913053A1 (en) | 2017-04-23 | 2021-11-24 | Illumina Cambridge Limited | Compositions and methods for improving sample identification in indexed nucleic acid libraries |
| DK3635136T3 (da) | 2017-06-07 | 2022-01-10 | Univ Oregon Health & Science | Enkeltcelle-helgenombiblioteker til methyleringssekvensering |
| WO2018232086A1 (en) * | 2017-06-14 | 2018-12-20 | Board Of Regents, The University Of Texas System | Chip hybridized association-mapping platform and methods of use |
| ES3055990T3 (en) | 2017-06-20 | 2026-02-17 | Illumina Inc | Methods for addressing inefficiencies in amplification reactions |
| GB201711219D0 (en) | 2017-07-12 | 2017-08-23 | Illumina Cambridge Ltd | Short pendant arm linkers for nucleotides in sequencing applications |
| EP3662482A1 (en) | 2017-07-31 | 2020-06-10 | Illumina Inc. | Sequencing system with multiplexed biological sample aggregation |
| WO2019023924A1 (en) | 2017-08-01 | 2019-02-07 | Helitec Limited | METHODS FOR ENRICHMENT AND DETERMINATION OF TARGET NUCLEOTIDE SEQUENCES |
| SG11201911869XA (en) | 2017-08-01 | 2020-01-30 | Illumina Inc | Spatial indexing of genetic material and library preparation using hydrogel beads and flow cells |
| EP4553172A3 (en) | 2017-08-01 | 2025-06-25 | MGI Tech Co., Ltd. | Nucleic acid sequencing method |
| GB201716931D0 (en) | 2017-10-16 | 2017-11-29 | Illumina Cambridge Ltd | New fluorescent compounds and their use as biomarkers |
| CN118126816A (zh) | 2017-11-06 | 2024-06-04 | 伊鲁米那股份有限公司 | 核酸索引化技术 |
| NZ759171A (en) | 2017-11-16 | 2022-05-27 | Illumina Inc | Systems and methods for determining microsatellite instability |
| CN110870016B (zh) | 2017-11-30 | 2024-09-06 | 伊鲁米那股份有限公司 | 用于序列变体呼出的验证方法和系统 |
| US11378544B2 (en) | 2018-01-08 | 2022-07-05 | Illumina, Inc. | High-throughput sequencing with semiconductor-based detection |
| KR102239487B1 (ko) | 2018-01-08 | 2021-04-14 | 일루미나, 인코포레이티드 | 반도체-기반 검출을 사용한 고-처리율 서열분석 |
| CN110832086A (zh) | 2018-04-02 | 2020-02-21 | 伊鲁米那股份有限公司 | 用于制造用于基于序列的遗传检验的对照的组合物和方法 |
| IL271454B2 (en) | 2018-05-17 | 2025-04-01 | Illumina Inc | Rapid single-cell genetic sequencing with low Aggregation bias |
| DK3810774T3 (da) | 2018-06-04 | 2023-12-11 | Illumina Inc | Enkeltcelletransskriptom-biblioteker med højt throughput og fremgangsmåder til fremstilling og anvendelse |
| NL2021377B1 (en) | 2018-07-03 | 2020-01-08 | Illumina Inc | Interposer with first and second adhesive layers |
| WO2020047005A1 (en) | 2018-08-28 | 2020-03-05 | 10X Genomics, Inc. | Resolving spatial arrays |
| US20210332424A1 (en) | 2018-08-28 | 2021-10-28 | 10X Genomics, Inc. | Methods of generating an array |
| US11519033B2 (en) | 2018-08-28 | 2022-12-06 | 10X Genomics, Inc. | Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample |
| EP3853358A1 (en) * | 2018-09-17 | 2021-07-28 | Omniome, Inc. | Engineered polymerases for improved sequencing |
| WO2020069424A1 (en) | 2018-09-28 | 2020-04-02 | Centrillion Technologies, Inc. | Disulfide-linked reversible terminators |
| EP3874036A1 (en) | 2018-10-31 | 2021-09-08 | Illumina, Inc. | Polymerases, compositions, and methods of use |
| NL2022043B1 (en) | 2018-11-21 | 2020-06-03 | Akershus Univ Hf | Tagmentation-Associated Multiplex PCR Enrichment Sequencing |
| WO2020117968A2 (en) | 2018-12-05 | 2020-06-11 | Illumina, Inc. | Polymerases, compositions, and methods of use |
| US12529094B2 (en) | 2018-12-10 | 2026-01-20 | 10X Genomics, Inc. | Imaging system hardware |
| WO2020123316A2 (en) | 2018-12-10 | 2020-06-18 | 10X Genomics, Inc. | Methods for determining a location of a biological analyte in a biological sample |
| US11293061B2 (en) | 2018-12-26 | 2022-04-05 | Illumina Cambridge Limited | Sequencing methods using nucleotides with 3′ AOM blocking group |
| US11649485B2 (en) | 2019-01-06 | 2023-05-16 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
| US11926867B2 (en) | 2019-01-06 | 2024-03-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
| CN114174531A (zh) | 2019-02-28 | 2022-03-11 | 10X基因组学有限公司 | 用空间条码化寡核苷酸阵列对生物分析物进行概况分析 |
| NL2023327B1 (en) | 2019-03-01 | 2020-09-17 | Illumina Inc | Multiplexed fluorescent detection of analytes |
| BR112021006234A2 (pt) | 2019-03-01 | 2021-09-28 | Illumina, Inc. | Bibliotecas de células únicas e núcleos únicos de alto rendimento e métodos de preparo e uso |
| WO2020178231A1 (en) | 2019-03-01 | 2020-09-10 | Illumina, Inc. | Multiplexed fluorescent detection of analytes |
| CA3103636A1 (en) | 2019-03-01 | 2020-09-10 | Illumina Cambridge Limited | Tertiary amine substituted coumarin compounds and their uses as fluorescent labels |
| BR112020026528B1 (pt) | 2019-03-01 | 2024-02-15 | Illumina Cambridge Limited | Composto de cumarina substituído com amina exocíclica, nucleotídeo ou oligonucleotídeo, kit, método de sequenciamento e método para sintetizar o referido composto |
| EP3938538A1 (en) | 2019-03-15 | 2022-01-19 | 10X Genomics, Inc. | Methods for using spatial arrays for single cell sequencing |
| EP3887542A1 (en) | 2019-03-22 | 2021-10-06 | 10X Genomics, Inc. | Three-dimensional spatial analysis |
| US11421271B2 (en) | 2019-03-28 | 2022-08-23 | Illumina Cambridge Limited | Methods and compositions for nucleic acid sequencing using photoswitchable labels |
| WO2020210370A1 (en) | 2019-04-12 | 2020-10-15 | Roche Sequencing Solutions, Inc. | Nucleic acid sequencing by synthesis using magnetic sensor arrays |
| WO2020243579A1 (en) | 2019-05-30 | 2020-12-03 | 10X Genomics, Inc. | Methods of detecting spatial heterogeneity of a biological sample |
| WO2021058438A1 (en) | 2019-09-23 | 2021-04-01 | Dna Script | Increasing long-sequence yields in template-free enzymatic synthesis of polynucleotides |
| EP4468252A3 (en) | 2019-10-01 | 2025-02-19 | 10x Genomics, Inc. | Systems and methods for identifying morphological patterns in tissue samples |
| EP4055155A1 (en) | 2019-11-08 | 2022-09-14 | Pacific Biosciences of California, Inc. | Engineered polymerases for improved sequencing by binding |
| WO2021091611A1 (en) | 2019-11-08 | 2021-05-14 | 10X Genomics, Inc. | Spatially-tagged analyte capture agents for analyte multiplexing |
| WO2021092433A2 (en) | 2019-11-08 | 2021-05-14 | 10X Genomics, Inc. | Enhancing specificity of analyte binding |
| WO2021102003A1 (en) | 2019-11-18 | 2021-05-27 | 10X Genomics, Inc. | Systems and methods for tissue classification |
| AU2020388573A1 (en) | 2019-11-21 | 2022-06-23 | 10X Genomics, Inc, | Spatial analysis of analytes |
| JP2023510454A (ja) | 2019-11-27 | 2023-03-14 | イルミナ ケンブリッジ リミテッド | シクロオクタテトラエンを含有する色素及び組成物 |
| AU2020407267A1 (en) | 2019-12-18 | 2022-06-16 | F. Hoffmann-La Roche Ag | Methods of sequencing by synthesis using a consecutive labeling scheme |
| JP2023508792A (ja) | 2019-12-19 | 2023-03-06 | イルミナ インコーポレイテッド | ハイスループット単一細胞ライブラリー、並びに製造方法及び使用方法 |
| EP4081656A1 (en) | 2019-12-23 | 2022-11-02 | 10X Genomics, Inc. | Compositions and methods for using fixed biological samples in partition-based assays |
| ES2982420T3 (es) | 2019-12-23 | 2024-10-16 | 10X Genomics Inc | Métodos para el análisis espacial mediante el uso de la ligazón con plantilla de ARN |
| CN115135984B (zh) | 2019-12-23 | 2025-12-23 | 10X基因组学有限公司 | 可逆固定试剂及其使用方法 |
| US12365942B2 (en) | 2020-01-13 | 2025-07-22 | 10X Genomics, Inc. | Methods of decreasing background on a spatial array |
| US12405264B2 (en) | 2020-01-17 | 2025-09-02 | 10X Genomics, Inc. | Electrophoretic system and method for analyte capture |
| US11702693B2 (en) | 2020-01-21 | 2023-07-18 | 10X Genomics, Inc. | Methods for printing cells and generating arrays of barcoded cells |
| US11732299B2 (en) | 2020-01-21 | 2023-08-22 | 10X Genomics, Inc. | Spatial assays with perturbed cells |
| US20210230681A1 (en) | 2020-01-24 | 2021-07-29 | 10X Genomics, Inc. | Methods for spatial analysis using proximity ligation |
| US12076701B2 (en) | 2020-01-31 | 2024-09-03 | 10X Genomics, Inc. | Capturing oligonucleotides in spatial transcriptomics |
| US12110541B2 (en) | 2020-02-03 | 2024-10-08 | 10X Genomics, Inc. | Methods for preparing high-resolution spatial arrays |
| US11898205B2 (en) | 2020-02-03 | 2024-02-13 | 10X Genomics, Inc. | Increasing capture efficiency of spatial assays |
| US12112833B2 (en) | 2020-02-04 | 2024-10-08 | 10X Genomics, Inc. | Systems and methods for index hopping filtering |
| US11732300B2 (en) | 2020-02-05 | 2023-08-22 | 10X Genomics, Inc. | Increasing efficiency of spatial analysis in a biological sample |
| WO2021158925A1 (en) | 2020-02-07 | 2021-08-12 | 10X Genomics, Inc. | Quantitative and automated permeabilization performance evaluation for spatial transcriptomics |
| CN115428088A (zh) | 2020-02-13 | 2022-12-02 | 10X基因组学有限公司 | 用于基因表达和dna染色质可及性的联合交互式可视化的系统和方法 |
| US12281357B1 (en) | 2020-02-14 | 2025-04-22 | 10X Genomics, Inc. | In situ spatial barcoding |
| CN115485391A (zh) | 2020-02-17 | 2022-12-16 | 10X基因组学有限公司 | 染色质相互作用的原位分析 |
| EP4484571A3 (en) | 2020-02-21 | 2025-03-19 | 10X Genomics, Inc. | Methods and compositions for integrated in situ spatial assay |
| US11891654B2 (en) | 2020-02-24 | 2024-02-06 | 10X Genomics, Inc. | Methods of making gene expression libraries |
| US12188085B2 (en) | 2020-03-05 | 2025-01-07 | 10X Genomics, Inc. | Three-dimensional spatial transcriptomics with sequencing readout |
| WO2021183403A2 (en) | 2020-03-10 | 2021-09-16 | Western Digital Technologies, Inc. | Magnetic sensor arrays for nucleic acid sequencing and methods of making and using them |
| CN115427586B (zh) | 2020-03-18 | 2025-03-28 | 深圳华大智造科技股份有限公司 | 大规模平行测序中的恢复阶段 |
| EP4139485B1 (en) | 2020-04-22 | 2023-09-06 | 10X Genomics, Inc. | Methods for spatial analysis using targeted rna depletion |
| US11188778B1 (en) | 2020-05-05 | 2021-11-30 | Illumina, Inc. | Equalization-based image processing and spatial crosstalk attenuator |
| AU2021269069A1 (en) | 2020-05-08 | 2022-10-20 | Illumina, Inc. | Genome sequencing and detection techniques |
| EP4150065A2 (en) | 2020-05-12 | 2023-03-22 | Illumina Inc | Generating nucleic acids with modified bases using recombinant terminal deoxynucleotidyl transferase |
| EP4414459B1 (en) | 2020-05-22 | 2025-09-03 | 10X Genomics, Inc. | Simultaneous spatio-temporal measurement of gene expression and cellular activity |
| EP4153776B1 (en) | 2020-05-22 | 2025-03-05 | 10X Genomics, Inc. | Spatial analysis to detect sequence variants |
| WO2021242834A1 (en) | 2020-05-26 | 2021-12-02 | 10X Genomics, Inc. | Method for resetting an array |
| US12031177B1 (en) | 2020-06-04 | 2024-07-09 | 10X Genomics, Inc. | Methods of enhancing spatial resolution of transcripts |
| EP4421186B1 (en) | 2020-06-08 | 2025-08-13 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
| WO2021252617A1 (en) | 2020-06-09 | 2021-12-16 | Illumina, Inc. | Methods for increasing yield of sequencing libraries |
| EP4165207B1 (en) | 2020-06-10 | 2024-09-25 | 10X Genomics, Inc. | Methods for determining a location of an analyte in a biological sample |
| US11787831B2 (en) | 2020-06-22 | 2023-10-17 | Illumina Cambridge Limited | Nucleosides and nucleotides with 3′ acetal blocking group |
| ES2994976T3 (en) | 2020-06-25 | 2025-02-05 | 10X Genomics Inc | Spatial analysis of dna methylation |
| US20210403993A1 (en) | 2020-06-30 | 2021-12-30 | Illumina, Inc. | Catalytically controlled sequencing by synthesis to produce scarless dna |
| US12168801B1 (en) | 2020-07-02 | 2024-12-17 | 10X Genomics, Inc. | Hybrid/capture probe designs for full-length cDNA |
| US11981960B1 (en) | 2020-07-06 | 2024-05-14 | 10X Genomics, Inc. | Spatial analysis utilizing degradable hydrogels |
| US11761038B1 (en) | 2020-07-06 | 2023-09-19 | 10X Genomics, Inc. | Methods for identifying a location of an RNA in a biological sample |
| US12209280B1 (en) | 2020-07-06 | 2025-01-28 | 10X Genomics, Inc. | Methods of identifying abundance and location of an analyte in a biological sample using second strand synthesis |
| CN116018412A (zh) | 2020-07-08 | 2023-04-25 | Illumina公司 | 作为转座体载体的小珠 |
| US11981964B2 (en) | 2020-07-28 | 2024-05-14 | Illumina Cambridge Limited | Substituted coumarin dyes and uses as fluorescent labels |
| US11981958B1 (en) | 2020-08-20 | 2024-05-14 | 10X Genomics, Inc. | Methods for spatial analysis using DNA capture |
| US12580044B1 (en) | 2020-09-02 | 2026-03-17 | 10X Genomics, Inc. | Systems and methods for identifying cells that are antigen-specific for an immunogenic feature |
| US11926822B1 (en) | 2020-09-23 | 2024-03-12 | 10X Genomics, Inc. | Three-dimensional spatial analysis |
| US12071667B2 (en) | 2020-11-04 | 2024-08-27 | 10X Genomics, Inc. | Sequence analysis using meta-stable nucleic acid molecules |
| US11827935B1 (en) | 2020-11-19 | 2023-11-28 | 10X Genomics, Inc. | Methods for spatial analysis using rolling circle amplification and detection probes |
| JP2023552015A (ja) | 2020-12-02 | 2023-12-14 | イルミナ ソフトウェア， インコーポレイテッド | 遺伝子変異を検出するためのシステム及び方法 |
| US12509717B2 (en) | 2020-12-11 | 2025-12-30 | 10X Genomics, Inc. | Methods and compositions for multimodal in situ analysis |
| US20220195516A1 (en) | 2020-12-17 | 2022-06-23 | Illumina Cambridge Limited | Methods, systems and compositions for nucleic acid sequencing |
| US20220195517A1 (en) | 2020-12-17 | 2022-06-23 | Illumina Cambridge Limited | Long stokes shift chromenoquinoline dyes and uses in sequencing applications |
| US20220195196A1 (en) | 2020-12-17 | 2022-06-23 | Illumina Cambridge Limited | Alkylpyridinium coumarin dyes and uses in sequencing applications |
| EP4729631A2 (en) | 2020-12-21 | 2026-04-22 | 10X Genomics, Inc. | Methods, compositions, and systems for capturing probes and/or barcodes |
| US20220195518A1 (en) | 2020-12-22 | 2022-06-23 | Illumina Cambridge Limited | Methods and compositions for nucleic acid sequencing |
| US12060603B2 (en) | 2021-01-19 | 2024-08-13 | 10X Genomics, Inc. | Methods for internally controlled in situ assays using padlock probes |
| US20220235403A1 (en) | 2021-01-26 | 2022-07-28 | 10X Genomics, Inc. | Nucleic acid analog probes for in situ analysis |
| EP4301873A1 (en) | 2021-03-03 | 2024-01-10 | 10X Genomics, Inc. | Analyte detection in situ using nucleic acid origami |
| MX2023011660A (es) | 2021-03-31 | 2023-12-11 | Illumina Cambridge Ltd | Tecnicas de secuenciacion de genoteca de acido nucleico con deteccion de dimero adaptador. |
| JP7719206B2 (ja) | 2021-04-02 | 2025-08-05 | イルミナ インコーポレイテッド | 配列決定のためのヌクレオチド－試料スライド内の泡を検出するための機械学習モデル |
| EP4305196B1 (en) | 2021-04-14 | 2025-04-02 | 10X Genomics, Inc. | Methods of measuring mislocalization of an analyte |
| WO2022232425A2 (en) | 2021-04-29 | 2022-11-03 | Illumina, Inc. | Amplification techniques for nucleic acid characterization |
| JP2024516191A (ja) | 2021-05-05 | 2024-04-12 | イルミナ ケンブリッジ リミテッド | ビス－ホウ素縮合複素環を含有する蛍光色素及び配列決定における使用 |
| EP4320271B1 (en) | 2021-05-06 | 2025-03-19 | 10X Genomics, Inc. | Methods for increasing resolution of spatial analysis |
| WO2022256324A1 (en) | 2021-06-01 | 2022-12-08 | 10X Genomics, Inc. | Methods and compositions for analyte detection and probe resolution |
| WO2022256422A1 (en) | 2021-06-02 | 2022-12-08 | 10X Genomics, Inc. | Sample analysis using asymmetric circularizable probes |
| US20220403450A1 (en) | 2021-06-03 | 2022-12-22 | Illumina Software, Inc. | Systems and methods for sequencing nucleotides using two optical channels |
| WO2022256503A1 (en) | 2021-06-03 | 2022-12-08 | 10X Genomics, Inc. | Methods, compositions, kits, and systems for enhancing analyte capture for spatial analysis |
| CN117597453A (zh) | 2021-06-23 | 2024-02-23 | 伊鲁米纳公司 | 用于测序试剂的组合物、方法、试剂盒、料筒和系统 |
| BR112023026615A2 (pt) | 2021-06-29 | 2024-03-05 | Illumina Inc | Métrica de relação sinal-ruído para determinar chamadas de bases de nucleotídeos e qualidade de chamadas de bases |
| WO2023278184A1 (en) | 2021-06-29 | 2023-01-05 | Illumina, Inc. | Methods and systems to correct crosstalk in illumination emitted from reaction sites |
| IL309368A (en) | 2021-06-29 | 2024-02-01 | Agilent Technologies Inc | polymerase mutants and use with 3'-OH UNBLOCKED REVERSIBLE TERMINATORS |
| EP4364155B1 (en) | 2021-06-29 | 2025-07-30 | Illumina, Inc. | Self-learned base caller, trained using oligo sequences |
| WO2023278966A1 (en) | 2021-06-29 | 2023-01-05 | Illumina, Inc. | Machine-learning model for generating confidence classifications for genomic coordinates |
| US12530882B2 (en) | 2021-07-01 | 2026-01-20 | Illumina, Inc. | Efficient artificial intelligence-based base calling of index sequences |
| WO2023288225A1 (en) | 2021-07-13 | 2023-01-19 | 10X Genomics, Inc. | Methods for preparing polymerized matrix with controllable thickness |
| WO2023287617A1 (en) | 2021-07-13 | 2023-01-19 | Illumina, Inc. | Methods and systems for real time extraction of crosstalk in illumination emitted from reaction sites |
| EP4374343B1 (en) | 2021-07-19 | 2025-12-03 | Illumina, Inc. | Intensity extraction with interpolation and adaptation for base calling |
| US11455487B1 (en) | 2021-10-26 | 2022-09-27 | Illumina Software, Inc. | Intensity extraction and crosstalk attenuation using interpolation and adaptation for base calling |
| US20230021577A1 (en) | 2021-07-23 | 2023-01-26 | Illumina Software, Inc. | Machine-learning model for recalibrating nucleotide-base calls |
| AU2022319125A1 (en) | 2021-07-28 | 2024-01-18 | Illumina, Inc. | Quality score calibration of basecalling systems |
| AU2022317053B2 (en) | 2021-07-30 | 2025-01-02 | 10X Genomics, Inc. | Methods and compositions for synchronizing reactions in situ |
| US12139751B2 (en) | 2021-07-30 | 2024-11-12 | 10X Genomics, Inc. | Circularizable probes for in situ analysis |
| US12553079B2 (en) | 2021-08-03 | 2026-02-17 | 10X Genomics, Inc. | Nucleic acid concatemers and methods for stabilizing and/or compacting the same |
| US12391984B2 (en) | 2021-08-03 | 2025-08-19 | 10X Genomics, Inc. | Compositions and methods for rolling circle amplification |
| WO2023014741A1 (en) | 2021-08-03 | 2023-02-09 | Illumina Software, Inc. | Base calling using multiple base caller models |
| US12460251B2 (en) | 2021-08-03 | 2025-11-04 | 10X Genomics, Inc. | Stabilization and/or compaction of nucleic acid molecules |
| US12529096B2 (en) | 2021-08-03 | 2026-01-20 | 10X Genomics, Inc. | Stabilization and/or compaction of nucleic acid structures |
| US12077789B2 (en) | 2021-08-14 | 2024-09-03 | Illumina, Inc. | Polymerases, compositions, and methods of use |
| EP4446426B1 (en) | 2021-08-16 | 2026-03-04 | 10X Genomics, Inc. | Probes comprising a split barcode region and methods of use |
| WO2023034489A1 (en) | 2021-09-01 | 2023-03-09 | 10X Genomics, Inc. | Methods, compositions, and kits for blocking a capture probe on a spatial array |
| EP4396376A1 (en) | 2021-09-01 | 2024-07-10 | Illumina, Inc. | Amplitude modulation for accelerated base calling |
| JP2024535663A (ja) | 2021-09-17 | 2024-10-02 | イルミナ インコーポレイテッド | ヌクレオチド配列決定における塩基コールエラーパターンからの障害ソースの自動的特定 |
| EP4405954A1 (en) | 2021-09-21 | 2024-07-31 | Illumina, Inc. | A graph reference genome and base-calling approach using imputed haplotypes |
| WO2023086880A1 (en) | 2021-11-10 | 2023-05-19 | 10X Genomics, Inc. | Methods, compositions, and kits for determining the location of an analyte in a biological sample |
| WO2023102118A2 (en) | 2021-12-01 | 2023-06-08 | 10X Genomics, Inc. | Methods, compositions, and systems for improved in situ detection of analytes and spatial analysis |
| WO2023102354A1 (en) | 2021-12-02 | 2023-06-08 | Illumina Software, Inc. | Generating cluster-specific-signal corrections for determining nucleotide-base calls |
| US20230183799A1 (en) | 2021-12-10 | 2023-06-15 | Illumina, Inc. | Parallel sample and index sequencing |
| EP4448786B1 (en) | 2021-12-16 | 2026-02-04 | Illumina, Inc. | Methods for metal directed cleavage of surface-bound polynucleotides |
| AU2022421156A1 (en) | 2021-12-20 | 2024-01-18 | Illumina, Inc. | Periodate compositions and methods for chemical cleavage of surface-bound polynucleotides |
| EP4453243B1 (en) | 2021-12-20 | 2026-02-11 | Illumina, Inc. | Periodate compositions and methods for chemical cleavage of surface-bound polynucleotides |
| WO2023122363A1 (en) | 2021-12-23 | 2023-06-29 | Illumina Software, Inc. | Dynamic graphical status summaries for nucelotide sequencing |
| US20230215515A1 (en) | 2021-12-23 | 2023-07-06 | Illumina Software, Inc. | Facilitating secure execution of external workflows for genomic sequencing diagnostics |
| EP4423296A2 (en) | 2021-12-27 | 2024-09-04 | 10X Genomics, Inc. | Methods and compositions for rolling circle amplification |
| US20230207050A1 (en) | 2021-12-28 | 2023-06-29 | Illumina Software, Inc. | Machine learning model for recalibrating nucleotide base calls corresponding to target variants |
| EP4457814A1 (en) | 2021-12-29 | 2024-11-06 | Illumina, Inc. | Automatically switching variant analysis model versions for genomic analysis applications |
| EP4733410A2 (en) | 2022-01-21 | 2026-04-29 | 10X Genomics, Inc. | Multiple readout signals for analyzing a sample |
| IL315106A (en) | 2022-02-23 | 2024-10-01 | Insitro Inc | Pooled optical screening and transcriptional measurements of cells comprising barcoded genetic perturbations |
| US20230313271A1 (en) | 2022-02-25 | 2023-10-05 | Illumina, Inc. | Machine-learning models for detecting and adjusting values for nucleotide methylation levels |
| JP2025507713A (ja) | 2022-02-25 | 2025-03-21 | イルミナ インコーポレイテッド | ヌクレオチド配列決定のための較正配列 |
| AU2023236924A1 (en) | 2022-03-15 | 2024-10-24 | Illumina, Inc. | Paired-end sequencing |
| US20230304086A1 (en) | 2022-03-28 | 2023-09-28 | Illumina Cambridge Limited | Labeled avidin and methods for sequencing |
| AU2023246772A1 (en) | 2022-03-29 | 2024-01-18 | Illumina Inc. | Chromenoquinoline dyes and uses in sequencing |
| CA3223037A1 (en) | 2022-03-30 | 2023-10-05 | Oliver MILLER | Methods for chemical cleavage of surface-bound polynucleotides |
| US20230357845A1 (en) | 2022-03-31 | 2023-11-09 | Illumina, Inc. | Compositions and methods for improving sequencing signals |
| WO2023192900A1 (en) | 2022-03-31 | 2023-10-05 | Illumina Singapore Pte. Ltd. | Nucleosides and nucleotides with 3' vinyl blocking group useful in sequencing by synthesis |
| EP4505177A1 (en) | 2022-04-01 | 2025-02-12 | 10x Genomics, Inc. | Compositions and methods for targeted masking of autofluorescence |
| US20230323427A1 (en) | 2022-04-06 | 2023-10-12 | 10X Genomics, Inc. | Methods and compositions for multiplex cell analysis |
| AU2023248405A1 (en) | 2022-04-07 | 2024-01-04 | Illumina, Inc. | Altered cytidine deaminases and methods of use |
| US20240287583A1 (en) | 2022-04-08 | 2024-08-29 | Illumina, Inc. | Aptamer dynamic range compression and detection techniques |
| WO2023212601A1 (en) | 2022-04-26 | 2023-11-02 | Illumina, Inc. | Machine-learning models for selecting oligonucleotide probes for array technologies |
| WO2023209606A1 (en) | 2022-04-29 | 2023-11-02 | Illumina Cambridge Limited | Methods and systems for encapsulating lyophilised microspheres |
| EP4519674A1 (en) | 2022-05-06 | 2025-03-12 | 10X Genomics, Inc. | Analysis of antigen and antigen receptor interactions |
| US20230368866A1 (en) | 2022-05-10 | 2023-11-16 | Illumina Software, Inc. | Adaptive neural network for nucelotide sequencing |
| US20250320487A1 (en) | 2022-05-18 | 2025-10-16 | Illumina, Inc. | Preparation Of Size-Controlled Nucleic Acid Fragments |
| CN119301275A (zh) | 2022-05-31 | 2025-01-10 | 伊路米纳有限公司 | 用于核酸测序的组合物和方法 |
| EP4540607A1 (en) | 2022-06-17 | 2025-04-23 | 10X Genomics, Inc. | Catalytic de-crosslinking of samples for in situ analysis |
| KR20250034034A (ko) | 2022-06-24 | 2025-03-10 | 일루미나, 인코포레이티드 | 후보 분할 그룹을 지능적으로 식별하고 채점함으로써 분할-판독 정렬을 개선하는 방법 |
| US20260011405A1 (en) | 2022-06-27 | 2026-01-08 | Illumina, Inc. | Human leukocyte antigen (hla) genotyping |
| CA3260497A1 (en) | 2022-06-27 | 2024-01-04 | Illumina, Inc. | ACCELERATORS FOR A GENOTYPE IMPOTENCY MODEL |
| CA3260482A1 (en) | 2022-06-27 | 2024-01-04 | Illumina, Inc. | GENERATION AND IMPLEMENTATION OF A STRUCTURAL VARIATION GRAPH GENOME |
| CN119604513A (zh) | 2022-06-28 | 2025-03-11 | 因美纳公司 | 含有稠合四环双硼杂环的荧光染料及其在测序中的用途 |
| US20240038327A1 (en) | 2022-07-26 | 2024-02-01 | Illumina Software, Inc. | Rapid single-cell multiomics processing using an executable file |
| US20240101978A1 (en) | 2022-08-12 | 2024-03-28 | 10X Genomics, Inc. | Puma1 polymerases and uses thereof |
| WO2024040060A1 (en) | 2022-08-16 | 2024-02-22 | 10X Genomics, Inc. | Ap50 polymerases and uses thereof |
| WO2024039516A1 (en) | 2022-08-19 | 2024-02-22 | Illumina, Inc. | Third dna base pair site-specific dna detection |
| KR20250073048A (ko) | 2022-09-16 | 2025-05-27 | 일루미나, 인코포레이티드 | 클러스터 분할 및 조건부 염기 호출 |
| CN118974830A (zh) | 2022-09-29 | 2024-11-15 | 因美纳有限公司 | 用于推算靶变体的靶变体参考组 |
| US20240141427A1 (en) | 2022-09-30 | 2024-05-02 | Illumina, Inc. | Polymerases, compositions, and methods of use |
| EP4594482A1 (en) | 2022-09-30 | 2025-08-06 | Illumina, Inc. | Cytidine deaminases and methods of use in mapping modified cytosine nucleotides |
| WO2024073519A1 (en) | 2022-09-30 | 2024-04-04 | Illumina, Inc. | Machine-learning model for refining structural variant calls |
| WO2024073043A1 (en) | 2022-09-30 | 2024-04-04 | Illumina, Inc. | Methods of using cpg binding proteins in mapping modified cytosine nucleotides |
| WO2024069581A1 (en) | 2022-09-30 | 2024-04-04 | Illumina Singapore Pte. Ltd. | Helicase-cytidine deaminase complexes and methods of use |
| US20240140939A1 (en) | 2022-09-30 | 2024-05-02 | Illumina Cambridge Limited | Compositions and methods for reducing photo damage during sequencing |
| KR20250081825A (ko) | 2022-10-05 | 2025-06-05 | 일루미나, 인코포레이티드 | 기계 학습 아키텍처를 활용하는 다중 서열분석 파이프라인의 변이 호출 통합 |
| EP4602608A1 (en) | 2022-10-11 | 2025-08-20 | Illumina, Inc. | Detecting and correcting methylation values from methylation sequencing assays |
| WO2024081869A1 (en) | 2022-10-14 | 2024-04-18 | 10X Genomics, Inc. | Methods for analysis of biological samples |
| WO2024102736A1 (en) | 2022-11-08 | 2024-05-16 | 10X Genomics, Inc. | Immobilization methods and compositions for in situ detection |
| EP4482979B1 (en) | 2022-11-09 | 2025-10-01 | 10X Genomics, Inc. | Methods, compositions, and kits for determining the location of multiple analytes in a biological sample |
| EP4573210B1 (en) | 2022-11-16 | 2026-05-06 | 10X Genomics, Inc. | Method for analysing gene expression in cells in a pellet |
| EP4619736A1 (en) | 2022-11-18 | 2025-09-24 | 10X Genomics, Inc. | Systems and methods for actively mitigating vibrations |
| EP4622746A1 (en) | 2022-11-22 | 2025-10-01 | 10X Genomics, Inc. | Systems and methods for interfacing with a bottle |
| US12581050B2 (en) | 2022-11-23 | 2026-03-17 | 10X Genomics, Inc. | Optical assemblies for machine vision calibration |
| EP4627583A1 (en) | 2022-11-30 | 2025-10-08 | Illumina, Inc. | Accurately predicting variants from methylation sequencing data |
| WO2024123866A1 (en) | 2022-12-09 | 2024-06-13 | Illumina, Inc. | Nucleosides and nucleotides with 3´ blocking groups and cleavable linkers |
| EP4634404A1 (en) | 2022-12-16 | 2025-10-22 | 10X Genomics, Inc. | Methods and compositions for assessing performance |
| EP4638789A1 (en) | 2022-12-21 | 2025-10-29 | 10X Genomics, Inc. | Methods for tethering ribonucleic acids in biological samples |
| US20240212791A1 (en) | 2022-12-21 | 2024-06-27 | Illumina, Inc. | Context-dependent base calling |
| US20240263219A1 (en) | 2023-01-06 | 2024-08-08 | 10X Genomics, Inc. | Methods and compositions for in situ analysis of variant sequences |
| EP4662663A1 (en) | 2023-02-06 | 2025-12-17 | Illumina, Inc. | Determining and removing inter-cluster light interference |
| WO2024191806A1 (en) | 2023-03-10 | 2024-09-19 | Illumina, Inc. | Aptamer detection techniques |
| WO2024206407A2 (en) | 2023-03-29 | 2024-10-03 | Illumina, Inc. | Naphthalimide dyes and uses in nucleic acid sequencing |
| EP4706045A1 (en) | 2023-03-30 | 2026-03-11 | Illumina, Inc. | Tandem repeat genotyping |
| EP4705515A1 (en) | 2023-05-03 | 2026-03-11 | 10X Genomics, Inc. | Methods and compositions for spatial assay |
| CA3260664A1 (en) | 2023-05-03 | 2024-11-07 | Illumina, Inc. | MACHINE LEARNING MODEL FOR RECALIBRATING GENOTYPE CALLS FROM EXISTING SEQUENCING DATA FILES |
| EP4720334A1 (en) | 2023-05-26 | 2026-04-08 | Illumina, Inc. | Methods for preserving methylation status during clustering |
| EP4721076A1 (en) | 2023-05-31 | 2026-04-08 | Illumina, Inc. | Improving structural variant alignment and variant calling by utilizing a structural-variant reference genome |
| WO2024249973A2 (en) | 2023-06-02 | 2024-12-05 | Illumina, Inc. | Linking human genes to clinical phenotypes using graph neural networks |
| WO2025006565A1 (en) | 2023-06-27 | 2025-01-02 | Illumina, Inc. | Variant calling with methylation-level estimation |
| EP4735635A1 (en) | 2023-06-30 | 2026-05-06 | Illumina, Inc. | Systems and methods of sequencing polynucleotides with alternative scatterplots |
| EP4735636A1 (en) | 2023-06-30 | 2026-05-06 | Illumina, Inc. | Systems and methods of sequencing polynucleotides with four labeled nucleotides |
| WO2025006874A1 (en) | 2023-06-30 | 2025-01-02 | Illumina, Inc. | Machine-learning model for recalibrating genotype calls corresponding to germline variants and somatic mosaic variants |
| EP4735634A1 (en) | 2023-06-30 | 2026-05-06 | Illumina, Inc. | Systems and methods of sequencing polynucleotides with modified bases |
| WO2025029831A1 (en) | 2023-07-31 | 2025-02-06 | 10X Genomics, Inc. | Methods and systems for targeted rna cleavage and target rna-primed rolling circle amplification |
| WO2025049720A2 (en) | 2023-08-31 | 2025-03-06 | Illumina, Inc. | Aptamer dynamic range compression and detection techniques |
| WO2025049700A1 (en) | 2023-08-31 | 2025-03-06 | Illumina, Inc. | Compositions and methods for nucleic acid sequencing |
| CN121969766A (zh) | 2023-08-31 | 2026-05-01 | 因美纳有限公司 | 适体检测技术 |
| WO2025054389A1 (en) | 2023-09-07 | 2025-03-13 | Illumina, Inc. | Identification of methylated cytosine using landmarks |
| WO2025050463A1 (en) | 2023-09-08 | 2025-03-13 | The Regents Of The University Of Michigan | MICRORNA-DERIVED RNAs AND POLYPEPTIDES AND USES THEREOF |
| WO2025061922A1 (en) | 2023-09-20 | 2025-03-27 | Illumina, Inc. | Methods for sequencing |
| WO2025061942A1 (en) | 2023-09-20 | 2025-03-27 | Illumina, Inc. | Sequencing error identification and correction |
| WO2025072783A1 (en) | 2023-09-28 | 2025-04-03 | Illumina, Inc. | Altered cytidine deaminases and methods of use |
| US20250111899A1 (en) | 2023-09-29 | 2025-04-03 | Illumina, Inc. | Predicting insert lengths using primary analysis metrics |
| WO2025072870A1 (en) | 2023-09-29 | 2025-04-03 | Illumina, Inc. | Tracking and modifying cluster location on nucleotide-sample slides in real time |
| WO2025081064A2 (en) | 2023-10-11 | 2025-04-17 | Illumina, Inc. | Thermophilic deaminase and methods for identifying modified cytosine |
| WO2025090596A1 (en) | 2023-10-26 | 2025-05-01 | Illumina, Inc. | 4,5-substituted naphthalimide dyes and uses in nucleic acid sequencing |
| WO2025090883A1 (en) | 2023-10-27 | 2025-05-01 | Illumina, Inc. | Detecting variants in nucleotide sequences based on haplotype diversity |
| US20250163505A1 (en) | 2023-11-17 | 2025-05-22 | Illumina, Inc. | Conjugated polymers or polymer dots as fluorescent labels |
| WO2025111463A1 (en) | 2023-11-22 | 2025-05-30 | 10X Genomics, Inc. | Methods for processing ribonucleic acids in biological samples |
| WO2025123005A2 (en) | 2023-12-07 | 2025-06-12 | Illumina, Inc. | Preparation and compositions of cot-1 nucleic acid |
| US20250201342A1 (en) | 2023-12-15 | 2025-06-19 | Illumina, Inc. | Minimal residual disease (mrd) models for determining likelihoods or probabilities of a subject comprising cancer |
| US20250201346A1 (en) | 2023-12-18 | 2025-06-19 | Illumina, Inc. | Using machine learning models for detecting minimum residual disease (mrd) in a subject |
| US20250197933A1 (en) | 2023-12-18 | 2025-06-19 | Illumina, Inc. | Hydrogel nanoparticles as labeling scaffold in sequencing |
| WO2025137222A1 (en) | 2023-12-19 | 2025-06-26 | Illumina, Inc. | Methylation detection assay |
| US20250207203A1 (en) | 2023-12-20 | 2025-06-26 | 10X Genomics, Inc. | In situ detection of copy number variations in biological samples |
| US20250210137A1 (en) | 2023-12-20 | 2025-06-26 | Illumina, Inc. | Directly determining signal-to-noise-ratio metrics for accelerated convergence in determining nucleotide-base calls and base-call quality |
| US20250210141A1 (en) | 2023-12-21 | 2025-06-26 | Illumina, Inc. | Enhanced mapping and alignment of nucleotide reads utilizing an improved haplotype data structure with allele-variant differences |
| US20250215494A1 (en) | 2023-12-29 | 2025-07-03 | Illumina, Inc. | Tricyclic polymethine dyes for nucleic acid sequencing |
| WO2025160089A1 (en) | 2024-01-26 | 2025-07-31 | Illumina, Inc. | Custom multigenome reference construction for improved sequencing analysis of genomic samples |
| WO2025174774A1 (en) | 2024-02-12 | 2025-08-21 | Illumina, Inc. | Determining offline corrections for sequence specific errors caused by low complexity nucleotide sequences |
| WO2025174708A1 (en) | 2024-02-13 | 2025-08-21 | Illumina, Inc. | Design and method for cross-sequencing platform compatibility of flow cells |
| WO2025178951A1 (en) | 2024-02-22 | 2025-08-28 | Illumina, Inc. | Techniques for dynamic range compression grouping in analyte assays |
| WO2025184234A1 (en) | 2024-02-28 | 2025-09-04 | Illumina, Inc. | A personalized haplotype database for improved mapping and alignment of nucleotide reads and improved genotype calling |
| WO2025193747A1 (en) | 2024-03-12 | 2025-09-18 | Illumina, Inc. | Machine-learning models for ordering and expediting sequencing tasks or corresponding nucleotide-sample slides |
| US20250288988A1 (en) | 2024-03-15 | 2025-09-18 | 10X Genomics, Inc. | Systems and methods for covering and sealing an open well |
| WO2025217057A1 (en) | 2024-04-08 | 2025-10-16 | Illumina, Inc. | Variant detection using improved sequence data alignments |
| WO2025221895A1 (en) | 2024-04-19 | 2025-10-23 | Illumina, Inc. | Water soluble polymer scaffolds for dye labeling |
| WO2025240241A1 (en) | 2024-05-13 | 2025-11-20 | Illumina, Inc. | Modifying sequencing cycles during a sequencing run to meet customized coverage estimations for a target genomic region |
| WO2025240918A1 (en) | 2024-05-17 | 2025-11-20 | 10X Genomics, Inc. | Systems and methods for generating codebooks |
| WO2025240924A1 (en) | 2024-05-17 | 2025-11-20 | Illumina, Inc. | Blind equalization systems for base calling applications |
| WO2025250794A1 (en) | 2024-05-31 | 2025-12-04 | Illumina, Inc. | Two-copy allele detection |
| WO2025250996A2 (en) | 2024-05-31 | 2025-12-04 | Illumina, Inc. | Call generation and recalibration models for implementing personalized diploid reference haplotypes in genotype calling |
| WO2025255457A1 (en) | 2024-06-07 | 2025-12-11 | 10X Genomics, Inc. | Compositions and methods for improved on-target spatial profiling |
| WO2025264702A1 (en) | 2024-06-18 | 2025-12-26 | 10X Genomics, Inc. | 3d hydrogels for nucleic acid sequencing |
| WO2026006746A2 (en) | 2024-06-28 | 2026-01-02 | Illumina, Inc. | Nucleic acid preparation and analysis techniques |
| WO2026006774A1 (en) | 2024-06-28 | 2026-01-02 | Illumina, Inc. | Altered cytidine deaminases and methods of use |
| WO2026006771A1 (en) | 2024-06-28 | 2026-01-02 | Illumina, Inc. | Cluster-filtering scores |
| WO2026030370A1 (en) | 2024-07-30 | 2026-02-05 | Illumina, Inc. | Generating adaptive intensity value decision boundaries for nucleotide sequencing |
| WO2026030369A1 (en) | 2024-07-31 | 2026-02-05 | 10X Genomics, Inc. | Methods and compositions for in situ analyte detection |
| WO2026035914A1 (en) | 2024-08-09 | 2026-02-12 | Illumina, Inc. | Nucleotides having 3'-hydroxy blocking groups |
| WO2026043885A1 (en) | 2024-08-20 | 2026-02-26 | 10X Genomics, Inc. | Methods and systems for preparing a nucleic acid library |
| WO2026072725A1 (en) | 2024-09-25 | 2026-04-02 | Illumina, Inc. | Adjusting oligonucleotide-cluster location in images in real time using band-edge spectral regions |
| WO2026072986A1 (en) | 2024-09-27 | 2026-04-02 | Illumina, Inc. | Determining offline corrections for sequence specific errors caused by low complexity sequences using a machine learning model |
| WO2026072436A1 (en) | 2024-09-27 | 2026-04-02 | Illumina, Inc. | Systems and methods for quantifying sequence read connectivity |
| WO2026072464A1 (en) | 2024-09-27 | 2026-04-02 | Illumina, Inc. | Read mapping enhanced by spatial information |
| WO2026073207A1 (en) | 2024-09-30 | 2026-04-02 | Illumina, Inc. | Affinity-binder-based assay compositions and methods |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756334A (en) | 1990-04-26 | 1998-05-26 | New England Biolabs, Inc. | Thermostable DNA polymerase from 9°N-7 and methods for producing the same |
| JP2003510063A (ja) | 1999-09-30 | 2003-03-18 | ニュー・イングランド・バイオラブズ・インコーポレイティッド | 古細菌のｄｎａポリメラーゼによる修飾ヌクレオチドの取り込み及びそれに関する方法 |
| US20030228616A1 (en) | 1999-10-29 | 2003-12-11 | Stratagene | DNA polymerase mutants with reverse transcriptase activity |
| DE60027040T2 (de) | 1999-10-29 | 2006-11-23 | Stratagene California, La Jolla | Zusammensetzungen und methoden zur verwendung von dna polymerasen |
| US8268605B2 (en) | 1999-10-29 | 2012-09-18 | Agilent Technologies, Inc. | Compositions and methods utilizing DNA polymerases |
| US7057026B2 (en) | 2001-12-04 | 2006-06-06 | Solexa Limited | Labelled nucleotides |
| WO2004018497A2 (en) | 2002-08-23 | 2004-03-04 | Solexa Limited | Modified nucleotides for polynucleotide sequencing |
| GB0321306D0 (en) | 2003-09-11 | 2003-10-15 | Solexa Ltd | Modified polymerases for improved incorporation of nucleotide analogues |
| EP1888743B1 (en) | 2005-05-10 | 2011-08-03 | Illumina Cambridge Limited | Improved polymerases |
-
2006
- 2006-05-10 EP EP06727060A patent/EP1888743B1/en active Active
- 2006-05-10 WO PCT/GB2006/001700 patent/WO2006120433A1/en not_active Ceased
- 2006-05-10 US US11/431,939 patent/US8623628B2/en not_active Expired - Fee Related
- 2006-05-10 JP JP2008510637A patent/JP4990886B2/ja not_active Expired - Fee Related
-
2013
- 2013-12-20 US US14/137,434 patent/US9273352B2/en active Active
-
2015
- 2015-12-01 US US14/956,231 patent/US20160115461A1/en not_active Abandoned
-
2017
- 2017-06-09 US US15/618,401 patent/US10059928B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20160115461A1 (en) | 2016-04-28 |
| US20170275602A1 (en) | 2017-09-28 |
| US20140287415A1 (en) | 2014-09-25 |
| US9273352B2 (en) | 2016-03-01 |
| US10059928B2 (en) | 2018-08-28 |
| EP1888743B1 (en) | 2011-08-03 |
| EP1888743A1 (en) | 2008-02-20 |
| US20060281109A1 (en) | 2006-12-14 |
| US8623628B2 (en) | 2014-01-07 |
| JP2008539750A (ja) | 2008-11-20 |
| WO2006120433A1 (en) | 2006-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4990886B2 (ja) | 改良ポリメラーゼ | |
| US11473067B2 (en) | Modified polymerases for improved incorporation of nucleotide analogues | |
| EP1152062B1 (en) | High temperature reverse transcription using mutant DNA polymerases | |
| US5939292A (en) | Thermostable DNA polymerases having reduced discrimination against ribo-NTPs | |
| CN101180390B (zh) | 改进的聚合酶 | |
| IL293820A (en) | Chimeric-terminal deoxynucleotidyltransferases for template-independent enzymatic synthesis of polynucleotides | |
| CA2581471A1 (en) | Mutant polymerases for sequencing and genotyping | |
| JP2006513726A (ja) | Ｄｎａポリメラーゼブレンドおよびその使用 | |
| EP4450620A1 (en) | Terminal transferase variant for controllable synthesis of single-stranded dna and use thereof | |
| EP2582808B1 (en) | Dna polymerases with increased 3'-mismatch discrimination | |
| AU2024230229A1 (en) | Engineered dna polymerase with reduced artifact formation | |
| EP2582806B1 (en) | Dna polymerases with increased 3'-mismatch discrimination | |
| HK1156353B (en) | Modified dna polymerases for improved incorporation of nucleotide analogues |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090508 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090508 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111108 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120207 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120214 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120307 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120403 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120502 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4990886 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150511 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |